BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Ziopharm Oncology to Host Conference Call to Discuss Third Quarter 2019 Results on November 7, 2019

  Ziopharm Oncology, Inc. announced that management will host a conference call and webcast on Thursday, November 7, at 4:30 p.m. ET to provide a corporate update and discuss financial results for the third quarter ended September 30, 2019.

  October 30, 2019

   · 

  1 min read
• Policy

  BPTF Testifies Before House Committee on Energy & Commerce About the Pharmaceutical Supply Chain

  Task Force Calls for Reasonable Regulations, More Collaboration among Stakeholders

  October 30, 2019

   · 

  2 min read
• Business

  Vanda Pharmaceuticals to Announce Third Quarter 2019 Financial Results on November 6, 2019

  Vanda Pharmaceuticals Inc. announced it will release results for the third quarter 2019 and provide a general business overview, on Wednesday, November 6, 2019, after the market closes..

  October 30, 2019

   · 

  1 min read
• Business

  PerkinElmer Announces Financial Results for the Third Quarter of 2019

  PerkinElmer, Inc., a global leader committed to innovating for a healthier world, reported financial results for the third quarter ended September 29, 2019.

  October 30, 2019

   · 

  34 min read
• Policy

  Brickell Biotech Provides Update on Bodor Labs Complaint and Funding Agreement with NovaQuest

  Brickell initiated arbitration proceedings against Bodor Labs and Nicholas S. Bodor including a claim for tortious interference

  October 30, 2019

   · 

  4 min read
• Drug Development

  Protagonist Therapeutics Initiates Phase 2 Study of Novel Hepcidin Mimetic PTG-300 in the Treatment of Patients with Polycythemia Vera

  Protagonist Therapeutics, Inc. announced that the first patient has been dosed in a Phase 2 study of PTG-300 in patients with polycythemia vera, a myeloproliferative disorder characterized by overproduction of red blood cells..

  October 30, 2019

   · 

  5 min read
• Business

  Vantage EyeCare, LLC Announces Continued Growth into 2020

  Vantage EyeCare, LLC is pleased to announce the addition of Dr. Allen Richmond to its Northern Ophthalmic Associates Division, and welcomes Valley Eye Professionals as its newest Division..

  October 30, 2019

   · 

  4 min read
• Business

  Nektar to Announce Financial Results for the Third Quarter 2019 on Wednesday, November 6, 2019, After Close of U.S.-Based Financial Markets

  Nektar Therapeutics will announce its financial results for the third quarter on Wednesday, November 6, 2019, after the close of U.S.-based financial markets.

  October 30, 2019

   · 

  1 min read
• Policy

  Knight and TherapeuticsMD Announce Filing of New Drug Submission for Joyesta™ in Canada

  Knight Therapeutics Inc. and TherapeuticsMD, Inc. announced today that Knight’s New Drug Submission for Joyesta™ has been accepted for review by Health Canada.

  October 30, 2019

   · 

  6 min read
• Biotech Beach

  Huntington Hospital named America’s 100 Best for Cardiac Care and 100 Best for Coronary Intervention

  New report identifies Huntington Hospital among the top hospitals nationally for excellence in Cardiac Care

  October 30, 2019

   · 

  3 min read